Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
One receptor
Tirzepatide works for weight loss by decreasing appetite and slowing the movement of food from the stomach into the small intestine, which may make you feel full more quickly and for a longer period of time
A 2023 study published in Diabetes, Obesity, and Metabolism demonstrated that GLP-1 agonist users engaging in regular physical activity experienced better weight loss quality, retaining more muscle mass compared to those who did not exercise
The most effective therapy available now is Zepbound, which causes about 20% weight loss
Food and Drug Administration approved this peptide in June 2019, highlighting its safety and efficacy, which can help women feel more confident in considering this treatment
